TDAC Translational Development Acqui
$10.86▼ -0.32%
Financials
Other
After hours
$10.89▲ +0.28%
Sep 11, 7:30 PM ET
Volume 15.7K
Avg Volume (10D) 16.5K
Key Metrics & Fundamentals
Market Cap
$209.69M
P/E Ratio
41.8
Div Yield
–%
52W Range
10.34 - 10.95
% vs 50 MA
0.51%
% vs 200 MA
2.14%
RSI-14
55.3
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.02
Free Cash Flow
-$338,753
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.27M
COGS
–
Operating Exp
$661,050
Operating Income
-$661,050
EBIT
-$661,050
Pretax Income
$946,982
Net Income
$946,982
EPS (Diluted)
0.04
Price & Volume History
Loading chart…
Recent News
ProLogium Appoints Antony Sheriff, CEO of Rimac Group, to Board of Directors
GlobeNewswire · Aug 24, 2026 1:31 PM
Translational Development Acquisition, Prologium Secure $50 Million Primary Capital Investment
MT Newswires · Jul 28, 2026 2:48 PM
ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination
GlobeNewswire · Jul 28, 2026 1:00 PM
TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger
PR Newswire · Jul 6, 2026 1:51 PM
TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote
PR Newswire · Jun 22, 2026 11:05 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See TDAC's money flow as a full page
Social Sentiment
No Reddit posts found for TDAC.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.